Several FDA-approved drugs — including for type 2 diabetes, hepatitis C and HIV — significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically, the team found that these drugs inhibit certain viral enzymes, called proteases, that are essential […]
Penn State University: Repurposing FDA-approved drugs may help combat COVID-19
- Post author:admin
- Post published:February 28, 2022
- Post category:Uncategorized
Tags: Education News